Overview
NCTY market data
Price History
NCTY price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.18 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.00 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -373.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.14 – $11.60 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $71.7M · P/B 2.50 · P/S 4.48.
Company News
The9 Says Investee Nanyang Biologics Received SEC Notice Of Effectiveness For Form F-4 Ahead Of Nasdaq Listing At $1.5B Pre-Transaction Valuation; Expects To Own 15% To 16% Of Combined CompanyBenzinga · Aug 11, 2026, 12:32 PM
The9 shares are trading higher after the company reported net income of $23 million for Q1 2026.Benzinga · Jul 27, 2026, 2:12 PM
The9 Names George Lai As Chief Executive Officer, Succeeding Founder Jun Zhu Effective July 27, 2026Benzinga · Jul 27, 2026, 5:25 AM
The9's Q1 2026 Net Income Hits $23M On 1.425B 9BIT Tokens, With 475M More Tokens Received In AprilBenzinga · Jul 27, 2026, 5:24 AM